Search

Your search keyword '"Baynes, C"' showing total 231 results

Search Constraints

Start Over You searched for: Author "Baynes, C" Remove constraint Author: "Baynes, C"
231 results on '"Baynes, C"'

Search Results

1. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

2. CYP3A7*1C allele:linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

3. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

5. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

6. Breast cancer risk genes - Association analysis in more than 113,000 women.

7. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

8. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

9. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

10. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

11. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

12. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

13. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

15. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

16. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study

17. 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans

18. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)

19. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

20. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

21. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

22. Association analysis identifies 65 new breast cancer risk loci

23. Rare, protein-truncating variants in $\textit{ATM}$, $\textit{CHEK2}$ and $\textit{PALB2}$, but not $\textit{XRCC2}$, are associated with increased breast cancer risks

24. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

25. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

26. Challenges Addressing Unmet Need for Contraception: Voices of Family Planning Service Providers in Rural Tanzania

27. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

28. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

30. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

31. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

32. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

33. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

34. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

35. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

36. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

37. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

38. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

39. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus

40. CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

41. High throughput SNP discovery in candidate genes

42. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

43. Prediction of breast cancer risk based on profiling with common genetic variants

44. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

45. Fine-scale mapping of the 4q24 locus identifies & pr two Independent loci associated with breast cancer risk

46. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

47. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

48. Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1

49. Genome-wide association analysis identifies three new breast cancer susceptibility loci

50. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

Catalog

Books, media, physical & digital resources